Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 years old and above with urolithiasis scheduled for shock wave lithotripsy.~Exclusion Criteria:~* Contraindications to Flomax~* Patients with renal impairment (serum creatinine above 2.0)~* Patients with hepatic impairment (liver enzymes 2.5 times the upper limit of normal)~* Use of other oral alpha blockers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Flomax (Type: EXPERIMENTAL): Patients on this arm will be given 0.4mg of Flomax to be taken for one month following their shock wave lithotripsy procedure.
- Sugar pill (Type: PLACEBO_COMPARATOR): Patients on this arm will be given a sugar pill to be taken for one month following their shock wave lithotripsy procedure.

Based on this trial design, predict the completion outcome and termination type (if applicable).